Clinical Trial Update: Improve the Survival Rate of Chinese Children and Adolescents With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial in China evaluating survival outcomes for children and adolescents with non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Childhood Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED